Targeting <scp>PI3Kα</scp> increases the efficacy of <scp>anti‐PD</scp>‐1 antibody in cervical cancer
Wei Jiang(China Electronics Technology Group Corporation), Huijuan Yang(Fudan University Shanghai Cancer Center)
Cited by 16
Related Papers
The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
|Journal of Hematology & Oncology|2018|106
Highly immunosuppressive HLADR<sup>hi</sup> regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma
|International Journal of Cancer|2019|29
Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma
|Cell Reports Medicine|2024|25
Power performance and dynamic characteristics of a 15 MW floating wind turbine with wave energy converter combined concept
|Sustainable Horizons|2024|17
A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer
|International Journal of Molecular Sciences|2023|5